Volume 22, Number 3—March 2016
Synopsis
Avian Influenza A(H5N1) Virus in Egypt
Ghazi Kayali
, Ahmed Kandeil, Rabeh El-Shesheny, Ahmed S. Kayed, Asmaa M. Maatouq, Zhipeng Cai, Pamela McKenzie, Richard Webby, Samir El Refaey, Amr Kandeel, and Mohamed A. Ali
, Ahmed Kandeil, Rabeh El-Shesheny, Ahmed S. Kayed, Asmaa M. Maatouq, Zhipeng Cai, Pamela McKenzie, Richard Webby, Samir El Refaey, Amr Kandeel, and Mohamed A. Ali
Table 2
H5 commercial inactivated oil-emulsion vaccines used for immunization of poultry against avian influenza A(H5N1) virus, Egypt, 2006
| Vaccine trade name |
Virus used |
Lineage |
Sequence similarity, % |
Manufacturer, city, country |
|---|---|---|---|---|
| AI-VAC H5 | A/chicken/Italy/22A/1998(H5N9) | Classical | 90.7 | FATRO, Ozzano dell'Emilia, Italy |
| CEVAC FLUKEM | A/chicken/Mexico/232/1994(H5N2) | Classical | 84 | Ceva, Mexico City, Mexico |
| VOLVAC IV KV | A/chicken/Mexico/232/1994(H5N2) | Classical | 84 | Boehringer Ingelheim, Ingelheim am Rhein, Germany |
| AIV Vaccine | A/turkey/Engl and /N28/1973(H5N2) | Classical | 91.4 | Yebio, Qingdao, China |
| AIV Vaccine | A/turkey/Minnesota/3689–1551/1981(H5N2) | Classical | 89.8 | Lohmann, Waterville, Maine, United States |
| Nobilis Influenza H5N2 | A/duck/Potsdam/1402/1986(H5N2) | Classical | 91.6 | Merck, Kenilworth, New Jersey, United States |
| Optimune AIV | A/turkey/Wisconsin/1968(H5N9) | Classical | 88.3 | Ceva Biomune, Mexico City, Mexico |
| Avian Influenza H5 | A/chicken/Mexico/232/1994(H5N2) | Classical | 84 | Avimex Animal Health Mexico City, Mexico |
| VOLVAC IV +ND KV | A/chicken/Mexico/232/94(H5N2) and Lasot and V | Classical | 84 | Boehringer Ingelheim, Ingelheim am Rhein, Germany |
| CEVAC NEW FLU-KEM | A/chicken/Mexico/232/94(H5N2) and Lasot and V | Classical | 84 | Ceva, Mexico City, Mexico |
| ITA FLU | A/chicken/Mexico/232/1994(H5N2) | Classical | 84 | Laprovet, Notre-Dame-d’Oé, France |
| Reassortant AIV (subtype H5N1) Vaccine (strain Re-1) | RGA/goose/Guangdong/1996(H5N1)(Re-1) | Clade 0 | 93.8 | Zhaoqing DaHuaNong Biology Medicine, Sihui, China |
| Reassortant AIV (Subtype H5N1) Vaccine (srain Re-1) | RGA/goose/Guangdong/1996(H5N1)(Re-1) | Clade 0 | 93.8 | Yebio, Qingdao, China |
| PoulvacFluFend H5N3 RG | RGA/chicken/VN/C58/2004(H5N3) | Clade 1 | 95.1 | Fort Dodge Animal Health, Fort Dodge, Iowa, USA |
| MEFLUVAC | RGA/chicken/Egypt/Q1995D/2010(H5N1) and RGA/chicken/Egypt/M2583D/2010(H5N1) | Clade 2.2 | 93.8 and 99.6 | ME-VAC, Cairo, Egypt |
| SER-VACC FLU | RGA/chicken/Egypt/M2583D/2010(H5N1) | Clade 2.2 | 99.6 | Veterinary Serum and Vaccine Institute, Cairo, Egypt |
| ME FLUVAC H5+H9 | RGA/chicken/Egypt/Q1995D/2010(H5N1) and A/chicken/Egypt/114940v/NLQP/2011(H9N2) | Clade 2.2 | 93.8 | ME-VAC, Cairo, Egypt |
| ME FLUVAC One | RGA/duck/Egypt/M2583D/2010(H5N1) | Clade 2.2 | 99.6 | ME-VAC, Cairo, Egypt |
| ME FLUVACH5+ ND | RGA/chicken/Egypt/Q1995D/2010(H5N1) and NDV/chicken/Egypt/11478AF/2011(ND) | Clade 2.2 | 93.8 | ME-VAC, Cairo, Egypt |
| ME FLUVAC Super H5 +H9+ ND | RGA/chicken/Egypt/Q1995D/2010(H5N1), RGA/duck/Egypt/M2583D/2010(H5N1), A/chicken/Egypt/114940v/NLQP/2011(H9N2), and NDV/chicken/Egypt/11478AF/2011(ND) | Clade 2.2 | 93.8 and 99.6 | ME-VAC, Cairo, Egypt |
| Egy FLU | RGA/chicken/Egypt/18-H/2009(H5N1) | Clade 2.2 | 94.9 | Harbin Veterinary Research Institute, Harbin, China |
| Inactivated Reassortant Avian Influenza Virus Vaccine (H5N1 Subtype, Re-6 Strain) | RGA/duck/Guangdong/S1322/2006(H5N1)(Re-6) | Clade 2.3.2 | Not performed | Yebio, Qingdao, China |
| Reassortant AIV (Subtype H5N1) Vaccine (Strain Re-5) | RGA/duck/Anhui/1/2006(H5N1)(Re-5) | Clade 2.3.4 | 94.9 | Merial, Duluth, Georgia, United States |
| Reassortant AIV (Subtype H5N1) Vaccine (Strain Re-5) | RGA/duck/Anhui/1/2006(H5N1)(Re-5) | Clade 2.3.4 | 94.9 | QYH, Beijing, China |
Page created: February 16, 2016
Page updated: February 16, 2016
Page reviewed: February 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.